Annual Total Debt
$51.77 M
+$49.28 M+1978.48%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual total debt is $51.77 million, with the most recent change of +$49.28 million (+1978.48%) on December 31, 2023.
- During the last 3 years, MIST annual total debt has risen by +$50.83 million (+5402.13%).
- MIST annual total debt is now at all-time high.
Performance
MIST Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$54.02 M
+$764.00 K+1.43%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly total debt is $54.02 million, with the most recent change of +$764.00 thousand (+1.43%) on September 30, 2024.
- Over the past year, MIST quarterly total debt has increased by +$2.99 million (+5.86%).
- MIST quarterly total debt is now at all-time high.
Performance
MIST Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
MIST Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1978.5% | +5.9% |
| 3 y3 years | +5402.1% | +8.7% |
| 5 y5 years | +100.0% | +8.7% |
MIST Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7317.6% | at high | +9668.2% |
| 5 y | 5-year | at high | +9973.0% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Milestone Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $54.02 M(+1.4%) |
| Jun 2024 | - | $53.25 M(+1.4%) |
| Mar 2024 | - | $52.51 M(+1.4%) |
| Dec 2023 | $51.77 M(+1978.5%) | $51.77 M(+1.5%) |
| Sep 2023 | - | $51.03 M(+1.4%) |
| Jun 2023 | - | $50.32 M(+1.3%) |
| Mar 2023 | - | $49.69 M(+1894.7%) |
| Dec 2022 | $2.49 M(+256.9%) | $2.49 M(-3.4%) |
| Sep 2022 | - | $2.58 M(+366.4%) |
| Jun 2022 | - | $553.00 K(-12.4%) |
| Mar 2022 | - | $631.00 K(-9.6%) |
| Dec 2021 | $698.00 K | $698.00 K(-8.9%) |
| Sep 2021 | - | $766.00 K(-7.9%) |
| Jun 2021 | - | $832.00 K(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $887.00 K(-5.7%) |
| Dec 2020 | $941.00 K(+83.1%) | $941.00 K(-1.2%) |
| Sep 2020 | - | $952.00 K(+229.4%) |
| Jun 2020 | - | $289.00 K(-18.4%) |
| Mar 2020 | - | $354.00 K(-31.1%) |
| Dec 2019 | $514.00 K(>+9900.0%) | $514.00 K(-11.7%) |
| Sep 2019 | - | $582.00 K(+146.6%) |
| Jun 2019 | - | $236.00 K(-13.2%) |
| Mar 2019 | - | $272.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00 |
| Dec 2017 | $0.00 | - |
FAQ
- What is Milestone Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual total debt year-on-year change?
- What is Milestone Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly total debt year-on-year change?
What is Milestone Pharmaceuticals annual total debt?
The current annual total debt of MIST is $51.77 M
What is the all time high annual total debt for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual total debt is $51.77 M
What is Milestone Pharmaceuticals annual total debt year-on-year change?
Over the past year, MIST annual total debt has changed by +$49.28 M (+1978.48%)
What is Milestone Pharmaceuticals quarterly total debt?
The current quarterly total debt of MIST is $54.02 M
What is the all time high quarterly total debt for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly total debt is $54.02 M
What is Milestone Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, MIST quarterly total debt has changed by +$2.99 M (+5.86%)